Aroa Soriano

Aroa graduated in Biology at the Universitat de Barcelona. She did her PhD thesis at the Department of Biochemistry and Molecular Biology, Faculty of Biology, Universitat de Barcelona under the supervision of Prof. E.I. Canela and Dr. V. Casadó (2009). During this period she studied the oligomerization between adenosine and dopamine receptors as a new therapeutic concept in Parkinson’s disease. Her first postdoctoral period (2009-2010) was at the Neuropharmacology and Pain Research Group at the IDIBELL-Universitat de Barcelona where she was trained under the supervision of Dr. F. Ciruela in the interaction of ion channels and G protein coupled receptors in Parkinson’s disease. Currently, she is a Postdoctoral Researcher of the Neural Pediatric Tumors Lab supervised by Dr. M. F. Segura at the Vall d’Hebron Research Institute where she is focused in the study of novel miRNA-based therapy for chemoresistant Neuroblastomas as well as the characterization of ERK5 in Neuroblastoma.